EpiPen maker finalizes settlement for government overcharges
TRENTON, N.J. (AP) — EpiPen maker Mylan has finalized a $465 million government agreement settling allegations it overbilled Medicaid for its emergency allergy injectors for a decade — charges brought after rival Sanofi filed a whistleblower lawsuit and tipped off the government.
It's the second settlement with the Department of Justice that Mylan has made since 2009 for allegedly overcharging the government for its medicines.
A prominent senator and a watchdog group both criticized the latest settlement for being far smaller than the amount Medicaid was overcharged.